Chimeric Antigen Receptor T-Cell Therapy in the Management of Relapsed Non-Hodgkin Lymphoma
Author:
Affiliation:
1. Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.01749
Reference83 articles.
1. HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA?
2. Graft-versus-leukemia reactions after bone marrow transplantation
3. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose
4. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advancements in nanomedicine delivery systems: unraveling immune regulation strategies for tumor immunotherapy;Nanomedicine;2024-07-16
2. Combination of chidamide and PD-1 blockade in Refractory/Relapsed aggressive large B-cell lymphomas with high risk of failing CAR-T therapy;International Immunopharmacology;2024-05
3. Cell Therapy: Actionable Takeaways from the 2023 Precision Oncology Summit Session;International Journal of Cancer Care and Delivery;2024-03-26
4. Living Long and Well After an Autograft;Journal of Clinical Oncology;2022-06-20
5. Post-CAR-T Cell Therapy (Consolidation and Relapse): Lymphoma;The EBMT/EHA CAR-T Cell Handbook;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3